Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
about
The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureMetabolic imaging in obesity: underlying mechanisms and consequences in the whole body.Predicting disease risk using bootstrap ranking and classification algorithms.High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.New insights into insulin resistance in the diabetic heart.Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistanceEffects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.The contribution of hibernation to heart failure.Evaluation of cardiac functions with tissue Doppler imaging in prediabetic subjectsMetabolic reserve of the heart: the forgotten link between contraction and coronary flow.Cardiac lipotoxicity: molecular pathways and therapeutic implications.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover studyLeft ventricular dysfunction in human immunodeficiency virus infection.Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.Lipid Use and Misuse by the Heart.Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited.LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes.MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.Sprint interval training decreases left-ventricular glucose uptake compared to moderate-intensity continuous training in subjects with type 2 diabetes or prediabetes.Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients.Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist.Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes.Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery.Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance."Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle".
P2860
Q28082343-973FCADC-CFCE-439D-9060-D8DE9EF8BB85Q30991322-F25382D8-F6D9-47B7-A1ED-E80B7144BF50Q31129426-74F8745C-3DC3-4297-9EDE-ECD62B461873Q33584533-692D459A-BD58-4671-B564-C11F4CE9BDFCQ33713702-98812ADE-3899-4345-892C-08FBE952D545Q33880303-F0EB75E0-9ABE-49DD-A4AA-44587D7F99ECQ33991754-C96B8A3A-EA21-450C-97A7-1BBCE06E39F1Q35243945-170D4876-D1BD-472B-A715-F48054FCDE11Q35529105-02795D70-728A-477B-A968-8477D8A2E25CQ35672526-765935BA-08B2-4479-ACBD-982F517BBE0BQ35932356-644CBCC9-D07A-41BF-9B99-E4B7EF51863DQ36681849-8989B970-53BF-479F-914E-35677DA3842BQ36821021-4EC3C7FF-6988-47D3-BC6E-254DBFFA1AE7Q36824112-7E0F5DD6-4C07-48AE-8447-99120FFD8926Q36844816-29F12868-1606-42FD-AC2D-2B1E8BEB2143Q37057956-5B421414-0F58-407B-A92A-37D1B1D114D7Q37095161-E883DFBD-398E-4206-B965-C7CCF4628888Q37125983-0CB609C9-3C13-4E7C-85C7-52BC821BB6BAQ37153504-F11212B8-04A5-454D-845E-1542EF916489Q37293974-42822208-3B82-406D-94D2-ACB77F542C71Q37684850-B176C9B1-F193-4556-B0E9-D423C4481545Q38218639-D734A2C5-D194-472B-AD20-5DD98A8D639BQ38264407-F6E700E6-393F-4CFF-BE20-9A04D0B6649CQ39038069-4B56E30D-9E06-4788-A6B0-75B8AF57B332Q41621302-E7C17471-829E-4E52-B0E1-5ACC4112DFA6Q44886445-17E00FE7-8809-4176-A8D8-0D5EDE0EDB5EQ46718590-5432E57D-2158-43B8-9E09-F379BD2904B2Q46944958-E58427D1-BE00-445B-9AB1-B7F25CFA4DE8Q47785505-19B3FD25-2BC4-4F0C-ACC0-1FC65E733F2EQ48175870-4743D987-1CA5-4B8C-BF75-BCEE765E2E77Q48199667-6A0DC7AB-8AC6-467D-AA13-A14B867476D1Q53775375-1D97A6C2-5D25-4709-8F61-8BF88B2D6D69
P2860
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Independent association of typ ...... myocardial insulin resistance.
@en
Independent association of typ ...... myocardial insulin resistance.
@nl
type
label
Independent association of typ ...... myocardial insulin resistance.
@en
Independent association of typ ...... myocardial insulin resistance.
@nl
prefLabel
Independent association of typ ...... myocardial insulin resistance.
@en
Independent association of typ ...... myocardial insulin resistance.
@nl
P2093
P1433
P1476
Independent association of typ ...... myocardial insulin resistance.
@en
P2093
D John Betteridge
David Dutka
Ele Ferrannini
Panithaya Chareonthaitawee
Paolo G Camici
P304
P356
10.2337/DIABETES.51.10.3020
P407
P577
2002-10-01T00:00:00Z